AUTL (STOCKS)
Autolus Therapeutics plc American Depositary Share
$1.510300
+0.020300 (+1.36%)
Prev close: $1.490000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Christian Martin Itin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $392.56M
- Employees
- 647
- P/E (TTM)
- -1.36
- P/B (TTM)
- 2.97
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
11
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.34 | $-0.27 | -0.0684 | -25.18% |
|
Sep 2025 (Q3)
|
$-0.30 | $-0.23 | -0.0698 | -30.32% |
|
Jun 2025 (Q2)
|
$-0.18 | $-0.24 | +0.0604 | +25.12% |
|
Mar 2025 (Q1)
|
$-0.26 | $-0.26 | -0.0050 | -1.96% |
Financial Statements
| Revenues | $75.39M |
| Benefits Costs and Expenses | $360.94M |
| Cost Of Revenue | $96.37M |
| Costs And Expenses | $360.94M |
| Gross Profit | -$20.98M |
| Nonoperating Income/Loss | -$15.01M |
| Operating Expenses | $249.56M |
| Selling, General, and Administrative Expenses | $131.87M |
| Research and Development | $117.69M |
| Operating Income/Loss | -$270.54M |
| Income/Loss From Continuing Operations After Tax | -$287.53M |
| Income/Loss From Continuing Operations Before Tax | -$285.56M |
| Income Tax Expense/Benefit | $1.97M |
| Income Tax Expense/Benefit, Current | $2.60M |
| Income Tax Expense/Benefit, Deferred | -$631.00K |
| Interest Expense, Operating | $36.67M |
| Net Income/Loss | -$287.53M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$287.53M |
| Net Income/Loss Available To Common Stockholders, Basic | -$287.53M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.08 |
| Diluted Earnings Per Share | -$1.08 |
| Basic Average Shares | 266,138,224 |
| Diluted Average Shares | 266,138,224 |
| Assets | $589.07M |
| Current Assets | $435.92M |
| Inventory | $33.21M |
| Prepaid Expenses | $21.28M |
| Other Current Assets | $381.43M |
| Noncurrent Assets | $153.15M |
| Fixed Assets | $63.56M |
| Other Non-current Assets | $89.59M |
| Liabilities | $410.94M |
| Current Liabilities | $73.44M |
| Accounts Payable | $3.08M |
| Wages | $26.22M |
| Other Current Liabilities | $44.13M |
| Noncurrent Liabilities | $337.50M |
| Equity | $178.13M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $178.13M |
| Liabilities And Equity | $589.07M |
| Net Cash Flow From Operating Activities | -$283.57M |
| Net Cash Flow From Operating Activities, Continuing | -$283.57M |
| Net Cash Flow From Investing Activities | $158.46M |
| Net Cash Flow From Investing Activities, Continuing | $158.46M |
| Net Cash Flow From Financing Activities | -$4.34M |
| Net Cash Flow From Financing Activities, Continuing | -$4.34M |
| Exchange Gains/Losses | $6.28M |
| Net Cash Flow | -$123.17M |
| Net Cash Flow, Continuing | -$129.45M |
| Comprehensive Income/Loss | -$263.71M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$263.71M |
| Other Comprehensive Income/Loss | -$263.71M |
| Other Comprehensive Income/Loss Attributable To Parent | $23.82M |